Takeover

Acquirers

Millendo Therapeutics, Inc.

Targets
1
Filings
1
Median premium
107%
First filing
Nov 6, 2018
Latest filing
Nov 6, 2018

Targets

CompanyScore before dealScore nowFilingsLatest
TPSTTempest Therapeutics, Inc.—0 / 131Nov 6, 2018

Deal filings

FiledCompanyFormPricePremium
Nov 6, 2018TPSTTempest Therapeutics, Inc.DEFM14A$0.11107%